Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Rossari Biotech Limited has informed the exchange regarding a Press Release dated October 21, 2023, titled "Rossari Biotech announces Q2 FY24 results".
22-10-2023
Bigul

Rossari Biotech Ltd - 543213 - Outcome Of Board Meeting-21.10.2023

The Board of Directors have interalia approved Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September, 2023 and other matters.
21-10-2023
Bigul

Rossari Biotech Ltd - 543213 - Board Meeting Outcome for Unaudited Financial Results For Quarter And Half Year Ended September 30, 2023

The Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the Quarter and half year ended September 30, 2023 of the Financial Year 2023-24 and other matters.
21-10-2023
Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Rossari Biotech Limited has informed the exchange regarding Allotment of 9330 Shares.
20-10-2023
Bigul

Rossari Biotech Ltd - 543213 - Announcement Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
19-10-2023

Rossari Biotech Share Price Live blog for 19 Oct 2023

Rossari Biotech stock price went up today, 19 Oct 2023, by 0.07 %. The stock closed at 801.95 per share. The stock is currently trading at 802.5 per share. Investors should monitor Rossari Biotech stock price closely in the coming days and weeks to see how it reacts to the news.
19-10-2023
Bigul

Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Earnings Conference Call for investors and analysts on Monday, October 23, 2023 at 05:00 P.M. IST
16-10-2023
Bigul

Rossari Biotech Ltd - 543213 - Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2023.

Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2023 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2023.
13-10-2023
Bigul

Rossari Biotech Ltd - 543213 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
10-10-2023
Next Page
Close

Let's Open Free Demat Account